If you're not following Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute, you're likely missing tons of great content emerging from ASCO #GU24. Check out the link below, and be sure to follow his handle for terrific updates from the meeting!

Proud of Georges Gebrael who is truly doing remarkable work with mentorship from Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute! ASCO TECAG ASCO #GU24

#GU24 Congrats Siqi Hu highlighted in The ASCO Post 📍 Prostate cancer pts had ⬆️mortality compared to urban population in Utah ↪️ Similar OS in the rural/urban pts treated Huntsman Cancer Institute in our paper 📝Rural disparity can be mitigated if pts were treated in a NCI cancer center

Make sure to stop by booth D13 to check out this fantastic work by #YeonjungJo on disparities in NGS tumor testing in more than 11K pts w/ mPCa #prostatecancer and 6K w/ aUC #bladdercancer 👇👇 Neeraj Agarwal, MD, FASCO Umang Swami OncoAlert UroToday.com PCF Science Bladder Cancer Advocacy Network

Congrats to Andrea Apolo, M.D. & the Alliance for Clinical Trials in Oncology SWOG Cancer Research Network NRG Oncology teams for the practice changing results👉Pembrolizumab as adjuvant therapy in MIBC #bladdercancer : Significantly improved DFS (HR: 0.69), OS immature, no new safety signals. Jonathan Rosenberg MD OncoAlert Uromigos

Practice impacting data by Dr. Bishoy M. Faltas #GU24 ASCO 👉Predicting clinical outcomes in the SWOG Cancer Research Network 1314 trial using a AI model integrating histopathology, cell types, and gene expression”👉AI biomarker will allow bladder preservation in #bladdercancer Thomas Flaig OncoAlert Uromigos

Just in Critical Reviews in Oncology Hematology (CROH) : Happy to share our review on the predictors of response to neoadjuvant therapy in urothelial cancer #Bladdercancer Gliceida Galarza, MD Umang Swami Georges Gebrael Vinay Mathew Thomas 👉 tinyurl.com/m6747xda OncoAlert UroToday.com GU Cancer Research Program @HuntsmanCancer

Matched in IM at my top choice. Thank you Parminder singh Irbaz Riaz MD,MS,MBI,PhD Alan H Bryce Mahesh Seetharam for your unwavering support and mentorship. A huge shoutout to my parents, Abhishek Tripathi Azra Borogovac Nishita Tripathi, MD coworkers Syed Arsalan Ahmed Naqvi Akshat Saxena Mayo Clinic Comprehensive Cancer Center Mayo Clinic Hematology-Oncology Fellowship

Just in ACS Journal Cancer 👉Pts w/ clear cell mRCC #kidneycancer from real world Flatiron database s/p ICI Rx👉 Similar survival w/ cabo + ICI vs. cabo monoRx aligning w/ #CONTACT03 trial results UroToday.com OncoAlert @huntsmangu Umang Swami Neeraj Agarwal, MD, FASCO 👇tinyurl.com/2w79fbt8

Just in Eur Urol Focus 👉🏻Pts w/ synchronous (Dx-Mx ≤ 3 mos) vs metachronous mRCC #kidneycancer treated w/ 1st line ICI Rx ➡️worse clinical outcomes 👇🏻 tinyurl.com/kheb6542 Georges Gebrael Luis A. Meza Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO GU Cancer Research Program @HuntsmanCancer Genitourinary Cancer Research Team @CityofHope UroToday.com OncoAlert

Great hosting Neeraj Agarwal, MD, FASCO back to Internal Medicine at Iowa grand-round, where he started his journey as a resident. Elegant talk. Nice to see familiar faces being acknowledged Umang Swami Benjamin L Maughan Nicolas Sayegh, MD Georges Gebrael @chadihc98 Sumanta K. Pal, MD, FASCO Petros Grivas Nishita Tripathi, MD #SumatiGupta

chadi nabhan MD, MBA, FACP Neeraj Agarwal, MD, FASCO Internal Medicine at Iowa Umang Swami Benjamin L Maughan Nicolas Sayegh, MD Georges Gebrael @chadihc98 Sumanta K. Pal, MD, FASCO Petros Grivas Nishita Tripathi, MD And got $1000000 NIH grant in hematology too Apparently he saw the light in prostate cancer few years later

Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US: 🟢Data from the Flatiron Health electronic health record database covering 280 oncology clinics 🟢 Treatments and patient attrition rates from January 2011 to January 2023.

Heartiest congratulations to Neeraj Agarwal, MD, FASCO and Adriana M Coletta, PhD, MS, RD for Huntsman Cancer Institute Collaborative Award for RO1 grant 👉 randomized trial of creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression

After all these years of knowing him, he never ceases to amaze. Whether its mentoring stellar residents/fellows/faculty (Umang Swami Andy Hahn Georges Gebrael et al), leading practice changing trials in #prostatecancer or driving collaborative research (exemplified by his R01 w

So insanely proud of Abhishek Tripathi City of Hope. Working with Brian Shuch, MD (my dear friend/coresident from UCLA Health days), he put together this analysis from SWOG Cancer Research Network 1500 that shows the utility (or lack thereof!) of the old system of papillary #kidneycancer subtyping (now in

A terrific review on #ADCs in solid tumors led by Salvador Jaime-Casas, MD, working alongside Regina Barragan-Carrillo & mentored by Abhishek Tripathi City of Hope. Salvador is a super hard-working, thoughtful & brilliant med school graduate from #MexicoCity. He's on a roll in his 1st yr with us, being

Just in JAMA Network Open 👉 Unacceptablely low rates of NGS testing in metastatic #ProstateCancer #bladdercancer in real world pts (worse in Black & Hispanic pts)Flatiron Health👇Proud of our postdoc, Chadi Chadi Hage Chehade , Yeonjung @yeonjungjohci, George Georges Gebrael & team👇

Congrats for really great work on this important issue @chadihc98 Georges Gebrael Nicolas Sayegh, MD Vinay Mathew Thomas Umang Swami Benjamin L Maughan Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute OncoAlert UroToday.com SWOG Cancer Research Network Sumanta K. Pal, MD, FASCO Toni Choueiri, MD Dr. Bishoy M. Faltas Hsieh Lab University of Utah Prostate Cancer Foundation Bladder Cancer Advocacy Network World Bladder Cancer Patient Coalition

🔶#Residencyand #Fellowshipmatch present specific challenges to #IMGs - IMGs have fewer opportunities to match into academic programs (Reddy et al. J Jan Intern Med 2021) - Non-US citizen IMG applicants are viewed by fellowship program directors as the most disadvantaged